Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

Biotech Fears Tough Restrictions From EU On Use of Primates

Sep. 12, 2007

By Peter O'Donnell

Nanobody Alliance With BI Could Net €200M For Ablynx

Sep. 12, 2007

By Peter O'Donnell

No Abstract

Generic Epoetin Products Win Approval From EU

Sep. 5, 2007

By Peter O'Donnell

Generic Epoetin Products Win Approval From EU

Sep. 5, 2007

By Peter O'Donnell

Nordic Countries Pushing For Support For Biotech Start-Ups

Aug. 29, 2007

By Peter O'Donnell

Nordic Countries Pushing For Support For Biotech Start-Ups

Aug. 29, 2007

By Peter O'Donnell

EU Mulls Conduct Code On Nanotechnology Use

Aug. 22, 2007

By Peter O'Donnell

EuropaBio: Biotech Is 'Crucial' To Hit Goals For Biofuels Use

Aug. 22, 2007

By Peter O'Donnell

EU Mulls Conduct Code On Nanotechnology Use

Aug. 22, 2007

By Peter O'Donnell

EuropaBio: Biotech Is 'Crucial' To Hit Goals For Biofuels Use

Aug. 22, 2007

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...